# Acrivon Therapeutics, Inc. (ACRV) insider trading

> In the 12 months to Nov 20, 2026, 7 ACRV insiders reported open-market sales of $39.8K across 9 filings; 3 insiders bought $114.3K.

Canonical: https://massive.com/quote/acrv/insider-trading
Latest filing: 2026-11-19 (last 12 months; source: SEC EDGAR)
Source: Massive (https://massive.com/docs/llms.txt)

## Summary

| Measure | Value | Detail |
| --- | --- | --- |
| Open-market sales | $39.8K | 9 filings · 7 insiders |
| Open-market purchases | $114.3K | 3 filings |

## Open-market trades by insider

| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
| --- | --- | --- | --- | --- | --- | --- |
| Kristina Masson | EVP - Business Operations | $33.4K | $82.1K | 3 | — | 2026-08-27 |
| Eric Devroe | Chief Operating Officer | $1.2K | $17.2K | 2 | — | 2026-08-20 |
| Adam D. Levy | Chief Financial Officer | $1.8K | $15.0K | 2 | — | 2026-08-06 |
| Mary Miller | Chief Legal Officer | $1.4K | — | 2 | — | 2026-08-20 |
| Peter Blume-Jensen | President and CEO | $973 | — | 1 | — | 2026-08-20 |
| Erick Gamelin | Chief Development Officer | $804 | — | 1 | — | 2026-08-20 |
| Katharine Peterson | Chief Accounting Officer | $203 | — | 1 | — | 2026-08-20 |

## Open-market trades by filing

12 filings in the last 12 months, newest first.

| Filed | Traded | Insider | Role | Type | Shares | Avg price | Value | Held after | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 2026-08-27 | 2026-08-25 | Kristina Masson | EVP - Business Operations | Sale | 14,036 | $2.21 | $31.0K | 2,230,052 | — |
| 2026-08-20 | 2026-08-18 | Kristina Masson | EVP - Business Operations | Sale | 1,229 | $2.01 | $2.5K | 2,244,088 | — |
| 2026-08-20 | 2026-08-18 | Peter Blume-Jensen | President and CEO | Sale | 484 | $2.01 | $973 | 385,859 | — |
| 2026-08-20 | 2026-08-18 | Eric Devroe | Chief Operating Officer | Sale | 604 | $2.01 | $1.2K | 146,349 | — |
| 2026-08-20 | 2026-08-18 | Erick Gamelin | Chief Development Officer | Sale | 400 | $2.01 | $804 | 52,592 | — |
| 2026-08-20 | 2026-08-18 | Mary Miller | Chief Legal Officer | Sale | 185 | $2.01 | $372 | 82,009 | — |
| 2026-08-20 | 2026-08-18 | Katharine Peterson | Chief Accounting Officer | Sale | 101 | $2.01 | $203 | 18,033 | — |
| 2026-08-06 | 2026-08-04 | Adam D. Levy | Chief Financial Officer | Sale | 1,142 | $1.57 | $1.8K | 66,008 | — |
| 2026-07-23 | 2026-07-21 | Mary Miller | Chief Legal Officer | Sale | 573 | $1.76 | $1.0K | 82,194 | — |
| 2026-01-16 | 2026-01-14 | Adam D. Levy | Chief Financial Officer | Purchase | 8,832 | $1.70 | $15.0K | 20,983 | — |
| 2026-01-16 | 2026-01-14 | Kristina Masson | EVP - Business Operations | Purchase | 49,000 | $1.68 | $82.1K | 2,095,771 | — |
| 2026-01-15 | 2026-01-13 | Eric Devroe | Chief Operating Officer | Purchase | 10,000 | $1.72 | $17.2K | 75,308 | — |

## Other insider activity (not market trades)

- Tax withholding: 17 records
- Tax withholding (sold to cover): 8 records
- Grants and awards: 17 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

## How to read this page

- **Open-market purchase or sale**: A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- **Filing date**: Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- **Counted once**: When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.

## FAQ

### Has Acrivon Therapeutics, Inc.'s CEO sold stock?

Yes. Peter Blume-Jensen (CEO) sold 484 shares ($973) in Aug 2026.

### How current is ACRV’s insider data?

These are ACRV Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

### What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

## Live data

This page joins two Massive endpoints: Form 4 filings and daily prices. The ACRV Form 4 request:

- `GET https://api.massive.com/stocks/filings/vX/form-4?tickers=ACRV&filing_date.gte=2025-11-20&sort=filing_date.desc&limit=500`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Acrivon Therapeutics, Inc. (ACRV) stock price](https://massive.com/quote/acrv.md)
- [Recent insider trading](https://massive.com/quote/insider-trading.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
